EDEMA - AN INFREQUENTLY RECOGNIZED COMPLICATION OF BROMOCRIPTINE AND OTHER ERGOT DOPAMINERGIC DRUGS

被引：16

作者：

BLACKARD, WG

机构：

[1] Medical College of Virginia, Richmond, VA

来源：

AMERICAN JOURNAL OF MEDICINE | 1993年 / 94卷 / 04期

关键词：

D O I：

10.1016/0002-9343(93)90160-Q

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：445 / 445

页数：1

共 4 条

[1] BROMOCRIPTINE AS PRIMARY THERAPY FOR PROLACTIN-SECRETING MACROADENOMAS - RESULTS OF A PROSPECTIVE MULTICENTER STUDY [J].

MOLITCH, ME ;

ELTON, RL ;

BLACKWELL, RE ;

CALDWELL, B ;

CHANG, RJ ;

JAFFE, R ;

JOPLIN, G ;

ROBBINS, RJ ;

TYSON, J ;

THORNER, MO .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (04) :698-705

[2] TREATMENT OF PROLACTIN-SECRETING PITUITARY MACROADENOMAS WITH THE LONG-ACTING NONERGOT DOPAMINE AGONIST CV-205-502 [J].

VANCE, ML ;

LIPPER, M ;

KLIBANSKI, A ;

BILLER, BMK ;

SAMAAN, NA ;

MOLITCH, ME .

ANNALS OF INTERNAL MEDICINE, 1990, 112 (09) :668-673

[3] CV 205-502 TREATMENT OF HYPERPROLACTINEMIA [J].

VANCE, ML ;

CRAGUN, JR ;

REIMNITZ, C ;

CHANG, RJ ;

RASHEF, E ;

BLACKWELL, RE ;

MILLER, MM ;

MOLITCH, ME .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (02) :336-339

[4] BROMOCRIPTINE [J].

VANCE, ML ;

EVANS, WS ;

THORNER, MO .

ANNALS OF INTERNAL MEDICINE, 1984, 100 (01) :78-91

← 1 →